InvestorsHub Logo

Roman516

03/03/23 7:00 PM

#573070 RE: iclight #573064

IC, once again, your personal opinion. NWBO's OS data results pass.
Multiple doctors, scientists and professional all agree.
Bullish
Bullish

$mith$on13

03/03/23 7:02 PM

#573072 RE: iclight #573064

another lie. :)

meirluc

03/03/23 7:09 PM

#573073 RE: iclight #573064

Even the dumbest GBM practitioner will be able to figure out that a placebo arm with 64 crossover patients and 28-29 permanent placebos that registered an mOS of over 24 months from randomization, owes its unusually long survival stats to the DCVax-L treatments that the 64 crossovers received after progression.

If anyone has a better explanation, please let me know.
Bullish
Bullish

ATLnsider

03/03/23 7:52 PM

#573077 RE: iclight #573064

Iclight, you do realize that Checkmate 548 clinical trial only included MGMT methylated GBM patients, right?

MGMT methylation is a positive prognostic factor.
Bullish
Bullish